vs
Side-by-side financial comparison of Dole plc (DOLE) and Solventum (SOLV). Click either name above to swap in a different company.
Dole plc is the larger business by last-quarter revenue ($2.3B vs $2.0B, roughly 1.1× Solventum). Solventum runs the higher net margin — 3.2% vs 0.2%, a 2.9% gap on every dollar of revenue. On growth, Dole plc posted the faster year-over-year revenue change (10.5% vs -3.7%). Dole plc produced more free cash flow last quarter ($66.5M vs $32.0M). Over the past eight quarters, Dole plc's revenue compounded faster (3.2% CAGR vs -0.4%).
Dole plc is an Irish-American agricultural multinational corporation headquartered in Dublin, Ireland. The company is among the world's largest producers of fruit and vegetables, operating with 38,500 full-time and seasonal employees who supply some 300 products in 75 countries. Dole reported 2021 revenues of $6.5 billion.
Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.
DOLE vs SOLV — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.3B | $2.0B |
| Net Profit | $5.1M | $63.0M |
| Gross Margin | 6.8% | 51.4% |
| Operating Margin | 1.1% | 6.3% |
| Net Margin | 0.2% | 3.2% |
| Revenue YoY | 10.5% | -3.7% |
| Net Profit YoY | -64.6% | 103.2% |
| EPS (diluted) | $0.05 | $0.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $2.0B | ||
| Q3 25 | $2.3B | $2.1B | ||
| Q2 25 | $2.4B | $2.2B | ||
| Q1 25 | $2.1B | $2.1B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | $2.1B | $2.1B | ||
| Q2 24 | $2.1B | $2.1B | ||
| Q1 24 | $2.1B | $2.0B |
| Q4 25 | — | $63.0M | ||
| Q3 25 | $5.1M | $1.3B | ||
| Q2 25 | $10.0M | $90.0M | ||
| Q1 25 | $38.9M | $137.0M | ||
| Q4 24 | — | $31.0M | ||
| Q3 24 | $14.4M | $122.0M | ||
| Q2 24 | $80.1M | $89.0M | ||
| Q1 24 | $70.1M | $237.0M |
| Q4 25 | — | 51.4% | ||
| Q3 25 | 6.8% | 54.2% | ||
| Q2 25 | 9.0% | 54.4% | ||
| Q1 25 | 8.7% | 53.8% | ||
| Q4 24 | — | 53.9% | ||
| Q3 24 | 8.0% | 56.0% | ||
| Q2 24 | 9.4% | 54.6% | ||
| Q1 24 | 9.2% | 58.1% |
| Q4 25 | — | 6.3% | ||
| Q3 25 | 1.1% | 80.6% | ||
| Q2 25 | 4.3% | 9.9% | ||
| Q1 25 | 3.2% | 7.3% | ||
| Q4 24 | — | 6.6% | ||
| Q3 24 | 2.3% | 13.2% | ||
| Q2 24 | 4.0% | 11.7% | ||
| Q1 24 | 5.3% | 18.9% |
| Q4 25 | — | 3.2% | ||
| Q3 25 | 0.2% | 60.4% | ||
| Q2 25 | 0.4% | 4.2% | ||
| Q1 25 | 1.9% | 6.6% | ||
| Q4 24 | — | 1.5% | ||
| Q3 24 | 0.7% | 5.9% | ||
| Q2 24 | 3.8% | 4.3% | ||
| Q1 24 | 3.3% | 11.8% |
| Q4 25 | — | $0.37 | ||
| Q3 25 | $0.05 | $7.22 | ||
| Q2 25 | $0.10 | $0.51 | ||
| Q1 25 | $0.41 | $0.78 | ||
| Q4 24 | — | $0.18 | ||
| Q3 24 | $0.15 | $0.70 | ||
| Q2 24 | $0.84 | $0.51 | ||
| Q1 24 | $0.74 | $1.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $321.0M | $878.0M |
| Total DebtLower is stronger | — | $5.0B |
| Stockholders' EquityBook value | $1.4B | $5.0B |
| Total Assets | $4.5B | $14.3B |
| Debt / EquityLower = less leverage | — | 1.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $878.0M | ||
| Q3 25 | $321.0M | $1.6B | ||
| Q2 25 | $323.1M | $492.0M | ||
| Q1 25 | $261.0M | $534.0M | ||
| Q4 24 | — | $762.0M | ||
| Q3 24 | $266.4M | $772.0M | ||
| Q2 24 | $225.8M | $897.0M | ||
| Q1 24 | $245.5M | $996.0M |
| Q4 25 | — | $5.0B | ||
| Q3 25 | — | $5.1B | ||
| Q2 25 | — | $7.8B | ||
| Q1 25 | — | $7.9B | ||
| Q4 24 | — | $8.0B | ||
| Q3 24 | — | $8.1B | ||
| Q2 24 | — | $8.3B | ||
| Q1 24 | — | $8.3B |
| Q4 25 | — | $5.0B | ||
| Q3 25 | $1.4B | $5.0B | ||
| Q2 25 | $1.4B | $3.6B | ||
| Q1 25 | $1.3B | $3.3B | ||
| Q4 24 | — | $3.0B | ||
| Q3 24 | $1.4B | $3.2B | ||
| Q2 24 | $1.4B | $2.9B | ||
| Q1 24 | $1.3B | $3.9B |
| Q4 25 | — | $14.3B | ||
| Q3 25 | $4.5B | $14.0B | ||
| Q2 25 | $4.7B | $15.1B | ||
| Q1 25 | $4.5B | $14.5B | ||
| Q4 24 | — | $14.5B | ||
| Q3 24 | $4.5B | $14.7B | ||
| Q2 24 | $4.4B | $14.6B | ||
| Q1 24 | $4.5B | $14.7B |
| Q4 25 | — | 1.00× | ||
| Q3 25 | — | 1.03× | ||
| Q2 25 | — | 2.14× | ||
| Q1 25 | — | 2.43× | ||
| Q4 24 | — | 2.71× | ||
| Q3 24 | — | 2.54× | ||
| Q2 24 | — | 2.90× | ||
| Q1 24 | — | 2.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $87.4M | $95.0M |
| Free Cash FlowOCF − Capex | $66.5M | $32.0M |
| FCF MarginFCF / Revenue | 2.9% | 1.6% |
| Capex IntensityCapex / Revenue | 0.9% | 3.2% |
| Cash ConversionOCF / Net Profit | 17.12× | 1.51× |
| TTM Free Cash FlowTrailing 4 quarters | $13.7M | $-10.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $95.0M | ||
| Q3 25 | $87.4M | $76.0M | ||
| Q2 25 | $18.3M | $169.0M | ||
| Q1 25 | $-78.8M | $29.0M | ||
| Q4 24 | — | $219.0M | ||
| Q3 24 | $101.0M | $169.0M | ||
| Q2 24 | $40.2M | $355.0M | ||
| Q1 24 | $-35.0M | $442.0M |
| Q4 25 | — | $32.0M | ||
| Q3 25 | $66.5M | $-21.0M | ||
| Q2 25 | $-1.0M | $59.0M | ||
| Q1 25 | $-131.6M | $-80.0M | ||
| Q4 24 | — | $92.0M | ||
| Q3 24 | $79.9M | $76.0M | ||
| Q2 24 | $22.8M | $297.0M | ||
| Q1 24 | $-53.2M | $340.0M |
| Q4 25 | — | 1.6% | ||
| Q3 25 | 2.9% | -1.0% | ||
| Q2 25 | -0.0% | 2.7% | ||
| Q1 25 | -6.3% | -3.9% | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | 3.9% | 3.7% | ||
| Q2 24 | 1.1% | 14.3% | ||
| Q1 24 | -2.5% | 16.9% |
| Q4 25 | — | 3.2% | ||
| Q3 25 | 0.9% | 4.6% | ||
| Q2 25 | 0.8% | 5.1% | ||
| Q1 25 | 2.5% | 5.3% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | 1.0% | 4.5% | ||
| Q2 24 | 0.8% | 2.8% | ||
| Q1 24 | 0.9% | 5.1% |
| Q4 25 | — | 1.51× | ||
| Q3 25 | 17.12× | 0.06× | ||
| Q2 25 | 1.84× | 1.88× | ||
| Q1 25 | -2.02× | 0.21× | ||
| Q4 24 | — | 7.06× | ||
| Q3 24 | 7.01× | 1.39× | ||
| Q2 24 | 0.50× | 3.99× | ||
| Q1 24 | -0.50× | 1.86× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DOLE
Segment breakdown not available.
SOLV
| Infection Prevention And Surgical Solutions | $752.0M | 38% |
| Cost Of Software And Rentals | $508.0M | 25% |
| Health Information Systems Segment | $347.0M | 17% |
| Dental Solutions Segment | $343.0M | 17% |
| Related Party | $14.0M | 1% |
